clinical research – The Hemp CBD Times

Cannabis Conundrum: Demonstrating “Accepted Medical Use” in a Restricted Research Environment

By Delia Ann Deschaine and Megan Robertson U.S. cannabis businesses operate in an increasingly complex legal and regulatory environment. Many,…

By hempcbdtimes , in 1961 Single Convention on Narcotic Drugs (the “Single Convention”) clinical research Congressional Research Service (CRS) Controlled Substance Act's Schedule 1 substances Drug Enforcement Administration (DEA) federal Multidisciplinary Association for Psychedelic Studies (MAPS) , at October 7, 2020

FDA’s Draft Guidance for Clinical Research Regarding Cannabis and Cannabis Derivatives Takes a Firm Stance on the 0.3% THC Level

By Agustin Rodriguez and Dascher Pasco On Tuesday, July 21, 2020, the U.S. Food and Drug Administration (FDA) issued “Cannabis…

By hempcbdtimes , in clinical research Draft Guidance Drug Enforcement Agency (DEA) Hemp Policy & Legal U.S. Food and Drug Administration (FDA) , at August 25, 2020

FDA Issues Draft Guidance For Cannabis Research

FDA Issues Draft Guidance For Cannabis Research The data obtained from these studies may later become part of a new…

By hempcbdtimes , in Cannabidiol Cannabis cannabis research clinical research FDA Food and Drug Administration Green Market Report News Research , at July 22, 2020

Category: clinical research

Cannabis Conundrum: Demonstrating “Accepted Medical Use” in a Restricted Research Environment

FDA’s Draft Guidance for Clinical Research Regarding Cannabis and Cannabis Derivatives Takes a Firm Stance on the 0.3% THC Level

FDA Issues Draft Guidance For Cannabis Research